Accord Healthcare introduces Pemetrexed Lyo. Injection to range of chemotherapy drugs

Astellas receives unfavourable decision in LEXISCAN(R) 0.4mg/mL US patent trial

Famotidine (Pepcid) Activates the Vagus Nerve to Reduce Cytokine Storm in COVID-19, New Study Shows

Ontario, British Columbia, Nova Scotia, New Brunswick, and Newfoundland Join List of Canadian Provinces Providing Public Drug Plan Reimbursement for Teva Canada's Ajovy for the Preventive Treatment of Migraine in Adults

UK Grants Licence for Teva's Ophthalmology Biosimilar Ongavia

Aztiq allies with Innobic to complete USD500m transaction to create international pharma powerhouse

Alcami partners with Civica Inc

Fresenius Kabi Launches New Generic for the Treatment of Multiple Myeloma

EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Efmody in Switzerland

US FDA Approves Veklury (Remdesivir) as Treatment for Pediatric Patients Under 12 Years of Age with COVID-19

Breckenridge Pharmaceutical signs new-product agreement with PTS Pharma

Dr. Reddy's Laboratories Launches Posaconazole Delayed-Release Tablets in the US Market

Breckenridge Pharmaceutical's ANDA for Miglustat Capsules, 100mg strength receives US FDA final approval

Nexus Pharmaceuticals unveils Erythromycin Lactobionate for Injection, USP in 500mg/vial

Revance Receives FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines